Sunitinib for Type B3 Thymoma or Thymic Carcinoma Previously Treated With Platinum-Based Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
STYLE (NCT03449173) a phase II Trial of Sunitinib in patients with type B3 Thymoma or Thymic Carcinoma in second and further lines
J Thorac Oncol 2023 Apr 22;[EPub Ahead of Print], C Proto, S Manglaviti, G Lo Russo, M Musca, G Galli, M Imbimbo, M Perrino, N Cordua, E Rulli, Z Ballatore, AD Maso, A Chella, A Sbrana, A Prelaj, R Ferrara, M Occhipinti, M Brambilla, A De Toma, L Mazzeo, T Beninato, D Signorelli, G Massa, FG Greco, G Calareso, D Miliziano, RM Di Mauro, G Mella, A Lucarelli, A Paggio, F Galli, V Torri, FGM de Braud, G Pasello, I Petrini, R Berardi, M Ganzinelli, M Garassino, P ZucaliFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.